Antibody seroconversion in asymptomatic and symptomatic patients infected with severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2)-Reference-Cited by-同舟云学术

Antibody seroconversion in asymptomatic and symptomatic patients infected with severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2)

Published:2020-01 Issue:9 Volume:9 Page:
ISSN:2050-0068
Container-title:Clinical & Translational Immunology
language:en
Short-container-title:Clin. Transl. Immunol.

Author:

Jiang Chuanhao¹,Wang Yali²,Hu Min¹,Wen Lingjun¹,Wen Chuan³,Wang Yang⁴,Zhu Weihong⁵,Tai Shi⁶,Jiang Zhongbiao⁷,Xiao Kui⁸,Faria Nuno Rodrigues⁹¹⁰,De Clercq Erik¹¹,Xu Junmei¹²,Li Guangdi¹²

Affiliation:

1. Department of Laboratory Medicine The Second Xiangya Hospital Central South University Changsha China

2. Hunan Provincial Key Laboratory of Clinical Epidemiology School of Public Health Central South University Changsha China

3. Department of Pediatrics The Second Xiangya Hospital Central South University Changsha China

4. Department of Social Affairs The Second Xiangya Hospital Central South University Changsha China

5. Department of Orthopedic Surgery The Second Xiangya Hospital Central South University Changsha China

6. Department of Cardiology The Second Xiangya Hospital Central South University Changsha China

7. Department of Radiology The Second Xiangya Hospital Central South University Changsha China

8. Department of Pulmonary and Critical Care Medicine The Second Xiangya Hospital Central South University Changsha China

9. Department of Zoology University of Oxford Oxford UK

10. Department of Infectious Disease Epidemiology School of Public Health Imperial College London London UK

11. Department of Microbiology, Immunology and Transplantation Rega Institute for Medical Research KU Leuven Leuven Belgium

12. Department of Anesthesiology The Second Xiangya Hospital Central South University Changsha China

Publisher

Wiley

Subject

General Nursing,Immunology,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cti2.1182

Reference52 articles.

1. Therapeutic options for the 2019 novel coronavirus (2019-nCoV)

2. Approved Antiviral Drugs over the Past 50 Years

3. Safety and potential efficacy of cyclooxygenase‐2 inhibitors in coronavirus disease 2019

4. Virological assessment of hospitalized patients with COVID-2019

5. Asymptomatic and Presymptomatic SARS-CoV-2 Infections in Residents of a Long-Term Care Skilled Nursing Facility — King County, Washington, March 2020

Cited by 66 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. COVID-19 antibody responses in individuals with natural immunity and with vaccination-induced immunity: a systematic review and meta-analysis;Systematic Reviews;2024-07-19

2. From Detection to Protection: Antibodies and Their Crucial Role in Diagnosing and Combatting SARS-CoV-2;Vaccines;2024-04-25

3. A comprehensive review on immunogen and immune-response proteins of SARS-CoV-2 and their applications in prevention, diagnosis, and treatment of COVID-19;International Journal of Biological Macromolecules;2024-02

4. Silent battles: immune responses in asymptomatic SARS-CoV-2 infection;Cellular & Molecular Immunology;2024-01-15

5. Epidemiological and clinical features of COVID-19 inpatients in Changsha, China: A retrospective study from 2020 to 2022;Heliyon;2023-12